AMBOSS Secures €240 Million to Enhance Global Medical Education and Care for Physicians

AMBOSS's Significant Financing Achievement

AMBOSS, a prominent player in the medical education and clinical decision-making sector, has successfully concluded a financing round of €240 million. This investment marks a significant stride for the company, which already holds a leading position in Germany and the United States. The new funding will be instrumental in exploring further international markets while enhancing its offerings to a broader range of healthcare professionals, including nurses.

New Investment Partners and Growth Strategy

The financing round attracted a mix of new long-term investors, including KIRKBI, MG Investments, and Lightrock, along with participation from existing shareholders. AMBOSS has also undergone a notable structural transformation by converting into a European stock corporation (SE). Co-Founder and Co-CEO Benedikt Hochkirchen noted the strategic choice of investors dedicated to AMBOSS's long-term vision, emphasizing a flexible investment duration. Many of the new investors manage evergreen funds, allowing them to stay involved until a potential IPO and beyond.

Hochkirchen added, "Additional funds will be directed towards advancing technology and exploring new market segments, alongside selective acquisitions, which remain integral to our growth strategy." This pledge comes on the heels of AMBOSS's earlier acquisition of Novaheal, an emerging player in nursing education, and NEJM Knowledge+, a valuable resource for medical exam preparation in the US, solidifying the company’s expansion in the healthcare domain.

Empowering Healthcare Professionals

AMBOSS is dedicated to digitally empowering physicians, ensuring that healthcare providers are equipped with the technologies they need to offer superior patient care. Physicians globally depend on AMBOSS to seamlessly integrate the latest medical knowledge with advanced technology. Co-Founder and Co-CEO Dr. Madjid Salimi stated, "Technology will not replace healthcare professionals, but those who adapt will lead the future of medicine."

Currently, over one million users across more than 180 countries place their trust in AMBOSS for vital clinical decision-making and educational resources. Impressively, AMBOSS supports every second inpatient treatment in Germany. In the United States, a majority of medical students utilize AMBOSS for exam preparation, achieving superior results compared to alternative question banks. Notably, 25% of first-year medical residents in the US rely on AMBOSS to facilitate their patient care efforts. The company’s approach is both straightforward and effective: medical experts compile pertinent knowledge, and AI-enhanced technology places it right at users' fingertips.

Leading with AI Expertise

The cornerstone of AMBOSS's success stems from fostering strong collaboration between seasoned medical professionals and technology experts. The platform offers precise, actionable advice on diagnostics and treatment grounded in the latest clinical guidelines, acting as a digital co-pilot in daily medical practices. This innovation helps save time and mitigate the risk of treatment errors. AMBOSS has long championed the responsible deployment of AI technologies, earning the trust of educators and clinicians alike.

Peter Bason, Head of Private Capital at KIRKBI, expressed enthusiasm for AMBOSS's growth trajectory, noting its successful expansion into the US market and unwavering focus on innovation. He emphasized the platform's evolution into an essential tool for medics and students alike, enhancing learning and informed decision-making at all stages. Bason expresses confidence in AMBOSS's leadership team as they embark on their ambitious mission to empower future healthcare professionals around the globe.

About AMBOSS

Founded in 2012 by a collective of physicians, AMBOSS is revolutionizing the acquisition and application of medical knowledge at the point of care. With a strong emphasis on quality content, innovative AI technology, and a user-centric approach, the organization has cultivated a diverse workforce of over 500 employees hailing from 50+ countries, inclusive of physicians, scientists, and software developers. With upward of 1 million users active in 180 countries, AMBOSS stands as a formidable presence in the global medical knowledge sector. For further inquiries, visit AMBOSS's official site.